Dianthus Therapeutics, Inc. (DNTH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 463K | 284K | 396K | 193K | 1.16M | 1.33M | 2.17M | 1.86M | 874K | 457K | 924K | 969K |
| Revenue Growth % | -60.19% | -78.58% | -81.77% | -89.64% | 33.07% | 190.15% | 135.06% | 92.26% | 83.61% | -61.11% | -21.23% | - |
| Cost of Goods Sold | 76K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19K | 84K |
| COGS % of Revenue | 16.41% | - | - | - | - | - | - | - | - | - | 2.06% | 8.67% |
| Gross Profit | 387K | 284K | 396K | 193K | 1.16M | 1.33M | 2.17M | 1.86M | 874K | 457K | 905K | 885K |
| Gross Margin % | 83.59% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 97.94% | 91.33% |
| Gross Profit Growth % | -66.72% | -78.58% | -81.77% | -89.64% | 33.07% | 190.15% | 140% | 110.51% | 83.61% | -59.41% | -22.85% | 174% |
| Operating Expenses | 46.92M | 69.83M | 40.68M | 35.12M | 34.34M | 33.24M | 32.07M | 24.07M | 18.72M | 13.41M | 16.66M | 12.66M |
| OpEx % of Revenue | 10133.91% | 24586.27% | 10273.74% | 18196.89% | 2952.71% | 2506.94% | 1476.61% | 1291.84% | 2141.65% | 2935.01% | 1803.46% | 1306.6% |
| Selling, General & Admin | 12.47M | 9.93M | 8.2M | 8.87M | 7.34M | 6.83M | 6.53M | 6M | 5.64M | 4.63M | 8.7M | 2.41M |
| SG&A % of Revenue | 2692.87% | 3496.48% | 2069.44% | 4595.34% | 630.87% | 515.01% | 300.55% | 321.9% | 645.31% | 1013.57% | 941.99% | 248.5% |
| Research & Development | 34.53M | 59.9M | 32.49M | 26.25M | 27M | 26.41M | 25.54M | 18.07M | 13.08M | 8.78M | 7.96M | 10.25M |
| R&D % of Revenue | 7457.45% | 21089.79% | 8204.29% | 13601.55% | 2321.84% | 1991.93% | 1176.06% | 969.94% | 1496.34% | 1921.44% | 861.47% | 1058.1% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -46.53M | -69.54M | -40.29M | -34.93M | -33.18M | -31.92M | -29.9M | -22.2M | -17.84M | -12.96M | -15.76M | -11.78M |
| Operating Margin % | -10050.32% | -24486.27% | -10173.74% | -18096.89% | -2852.71% | -2406.94% | -1376.61% | -1191.84% | -2041.65% | -2835.01% | -1705.52% | -1215.27% |
| Operating Income Growth % | -40.26% | -117.89% | -34.74% | -57.3% | -85.93% | -146.34% | -89.73% | -88.55% | -132.25% | -21.16% | -90.93% | 34.88% |
| EBITDA | -46.46M | -69.28M | -40.26M | -34.83M | -33.04M | -31.84M | -29.78M | -22.09M | -17.74M | -12.85M | -15.74M | -11.69M |
| EBITDA Margin % | -10033.91% | -24395.07% | -10166.92% | -18045.6% | -2841.27% | -2401.06% | -1371.27% | -1185.88% | -2029.4% | -2812.47% | -1703.46% | -1206.6% |
| EBITDA Growth % | -40.59% | -117.61% | -35.18% | -57.64% | -86.3% | -147.71% | -89.22% | -88.96% | -131.28% | -20.75% | -90.93% | 30.76% |
| D&A (Non-Cash Add-back) | 76K | 259K | 27K | 99K | 133K | 78K | 116K | 111K | 107K | 103K | 19K | 84K |
| EBIT | -46.53M | -69.54M | -36.77M | -34.93M | -33.18M | -31.92M | -29.9M | -22.2M | -17.84M | -12.96M | -14.76M | -13.06M |
| Net Interest Income | 6.26M | 5.27M | 3.66M | 3.4M | 3.79M | 3.99M | 4.45M | 4.71M | 4.22M | 2.44M | 1.03M | 687K |
| Interest Income | 6.26M | 5.27M | 3.66M | 3.4M | 3.79M | 3.99M | 4.45M | 4.71M | 4.22M | 2.44M | 1.03M | 687K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 5.7M | 167.45M | 3.52M | 3.3M | 3.67M | 3.48M | 4.73M | 4.6M | 4.1M | 2.39M | 996K | 636K |
| Pretax Income | -40.83M | 97.91M | -36.77M | -31.63M | -29.51M | -28.44M | -25.17M | -17.61M | -13.75M | -10.56M | -14.76M | -11.14M |
| Pretax Margin % | -8819.44% | 34473.59% | -9284.09% | -16388.08% | -2537.49% | -2144.8% | -1159.02% | -945.09% | -1573% | -2311.38% | -1597.73% | -1149.64% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -40.83M | 97.91M | -36.77M | -31.63M | -29.51M | -28.44M | -25.17M | -17.61M | -13.75M | -10.56M | -14.76M | -11.14M |
| Net Margin % | -8819.44% | 34473.59% | -9284.09% | -16388.08% | -2537.49% | -2144.8% | -1159.02% | -945.09% | -1573% | -2311.38% | -1597.73% | -1149.64% |
| Net Income Growth % | -38.37% | 444.25% | -46.04% | -79.64% | -114.66% | -169.24% | -70.52% | -58.05% | -93.93% | -4.42% | -89.66% | 35.5% |
| Net Income (Continuing) | -40.83M | 97.91M | -36.77M | -31.63M | -29.51M | -28.44M | -25.17M | -17.61M | -13.75M | -10.56M | -14.76M | -11.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 | -0.54 | -2.33 | -3.78 | -0.87 |
| EPS Growth % | -3.66% | 419.75% | -31.08% | -72.55% | -51.85% | 65.24% | 80.42% | 41.38% | 92.99% | 12.73% | -79.94% | 81.49% |
| EPS (Basic) | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 | -0.81 | -0.74 | -0.51 | -0.54 | -2.33 | -3.78 | -0.87 |
| Diluted Shares Outstanding | 48.03M | 37.79M | 37.79M | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M |
| Basic Shares Outstanding | 48.03M | 37.79M | 37.79M | 35.82M | 35.79M | 35.03M | 34.24M | 34.23M | 25.67M | 4.53M | 3.91M | 3.79M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |